Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Aug 22;27(12):1424–1432. doi: 10.1158/1055-9965.EPI-18-0446

Table 1:

Patient-level social disadvantage and patient health and healthcare utilization characteristics by colorectal cancer (CRC) screening test use during 18-month follow-up period for age- and screening-eligible sample (N=32,965); Pct: Percent; SD: Standard deviation; IQR: Interquartile mean; ED: Emergency department.

Overall Screened
N Pct N Pct P-value
(Mean) (SD) (Mean) (SD)
Patient Social Disadvantage
    Age (55.17) (4.06) (55.14) (4.12) 0.3
    Sex
        Female 19,862 0.6 9,256 0.62 <0.001
        Male 13,103 0.4 5,607 0.38
    Race/Ethnicity
        African American 12,202 0.37 5,009 0.34 <0.001
        Hispanic 12,860 0.39 6,766 0.46
        Other 1,853 0.06 784 0.05
        White 6,050 0.18 2,304 0.15
    Language
        English 21,914 0.66 8,854 0.6 <0.001
        Spanish 9,562 0.29 5,344 0.36
        Other 1,343 0.04 641 0.04
        Unknown 146 0.01 24 0
    Charlson index1
        0 18,525 0.56 8,549 0.58 <0.001
        2-Jan 12,332 0.37 5,586 0.38
        3+ 2,108 0.06 728 0.05
Healthcare Utilization Factors
    Clinic2 <0.001
    Patient has primary care provider 15,160 0.46 7,440 0.5 <0.001
    Payer type
        Commercial 2,051 0.06 498 0.03 <0.001
        Medicaid 2,862 0.09 938 0.06
        Medicare 2,399 0.07 888 0.06
        Other 637 0.02 347 0.02
        Uninsured 25,016 0.76 12,192 0.82
    Payer type changed3 6,684 0.2 3,151 0.21 <0.001
    # primary care visits3 (4.18) (2.75) (4.71) (2.63) <0.001
    # ED care visits3 (0.85) (2.79) (0.83) (2.25) 0.05
    # missed care visits3 (2.27) (2.77) (2.31) (2.71) <0.001
Total 32,965 1 14,863 45.12
1

Measured in year prior to index visit

2

Clinic indicators not shown

3

Measured in 18-month follow-up period.